Home > Healthcare > Medical Devices > Diagnostic Devices > Carrier Screening Market

Carrier Screening Market Share

Report ID: GMI5759
Published Date: May 2023
Report Format: PDF

Download Free Sample

Carrier Screening Market Share

Few of the leading players operating in the carrier screening market include:

Fulgent Genetics Inc.
Thermo Fisher Scientific Inc.
BGI Genomics
InVitae Corporation
Quest Diagnostics Inc.
Illumina Inc.
Myriad Genetics, Inc.

The market is fragmented in nature, with leading players, regional and local companies, along with start-ups improving the industry competition. The leading market players are involved in strategic developments including novel product launch, research and development, collaborations, to improve their market positioning and revenue generating capabilities.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for carrier screening was valued at around USD 2 billion in 2023 and is estimated to amass more than USD 6 billion by the end of 2032 owing to the increasing awareness of the possibility of genetic risks among couples.

The expanded carrier screening segment is expected to account for around USD 3.7 billion in 2032 attributed to the increasing product use in screening of multiple genetic disorders.

North America market for carrier screening is projected to reach over USD 2.3 billion by 2032 driven by the high R&D spending for different genetic complications and the availability of a wide range of carrier screening products.

Fulgent Genetics Inc., Thermo Fisher Scientific Inc., BGI Genomics, InVitae Corporation, Quest Diagnostics Inc., Illumina Inc., and Myriad Genetics, Inc. are some of the top companies in the global carrier screening market.